_id
690db098ccc777a4e85d0b91
Ticker
ARGNF
Name
argenx SE
Exchange
OTCGREY
Address
Laarderhoogtweg 25, Amsterdam, Netherlands, 1101 EB
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://argenx.com
Description
argenx SE, a commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally. The company offers VYGART and VYGART HYTRULO to treat generalized myasthenia gravis (gMG), immune thrombocytopenia (ITP), and chronic inflammatory demyelinating polyneuropathy (CIDP). It also develops efgartigimod for the treatment of seronegative and ocular gMG, thyroid eye diseases, ITP, myositis, Sjögren's disease, lupus nephropathy, systemic sclerosis, antibody-mediated rejection, and autoimmune encephalitis; empasiprubart for multifocal motor neuropath, CIDP, delayed graft function, and dermatomyositis; and ARGX-119 for congenital myasthenic syndrome, amyotrophic lateral sclerosis, and spinal muscular atrophy. In addition, the company is also developing ARGX-119, a MuSK agonist to treat congenital myasthenic syndromes and amyotrophic lateral sclerosis; ARGX-109, which targets IL-6 to treat inflammation; ARGX-121 and ARGX 220 that targets the immune system; ARGX-213, which targets FcRn; and ARGX-118, which develops antibodies against Galectin-10, as well as cusatuzumab, ARGX-112, ARGX-114, and ARGX-115. It has strategic collaborations with OncoVerity, Inc, LEO Pharma A/S, Zai Lab Limited, AbbVie, Inc., Elektrofi, Genmab SE, Chugai Pharmaceutical Co., Ltd., Clayton Foundation, Halozyme Therapeutics, Inc., AgomAb Therapeutics NV, Broteio Pharma B.V., VIB vzw, University of Texas, BioWa, Inc., Lonza Sales AG, Université Catholique de Louvain, Sopartec S.A., NYU Langone Health, Leiden University Medical Center, and IQVIA Ltd. argenx SE was incorporated in 2008 and is based in Amsterdam, the Netherlands.
Last Close
840
Volume
2
Current Price
816.9
Change
0
Last Updated
2026-01-20T15:37:56.607Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
50858913792
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.7772444444444444
Sentiment Sources
9
Current Quarter
2025-09-30
Revenue
1126961000
Cost Of Revenue
109426000
Gross Profit
1017535000
Operating Expenses
776991000
Operating Income
349970000
Interest Expense
993000
Pretax Income
386053000
Net Income
344258000
Eps
-
Dividends Per Share
-
Shares Outstanding
61883406
Income Tax Expense
-
EBITDA
-
Operating Margin
31.05431332583825
Total Other Income Expense Net
-5624000
Cash
-
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
-
Property Plant Equipment
-
Total Assets
-
Payables
-
Short Term Debt
-
Long Term Debt
-
Total Liabilities
-
Equity
-
Bs_currency_symbol
-
Depreciation
-
Change In Working Capital
-
Cash From Operations
-
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
-
Cf_currency_symbol
USD
PE
34.97
PB
-
ROE
-
ROA
-
FCF
-
Fcf Percent
-
Piotroski FScore
1
Health Score
46
Deep Value Investing Score
1
Defensive Investing Score
3
Dividend Investing Score
1.5
Economic Moat Investing Score
5
Garp Investing Score
1.5
Growth Investing Score
1.5
Momentum Investing Score
4
Net Net Investing Score
0
Quality Investing Score
4
Value Investing Score
1
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
1126961000
Quarters > 0 > income Statement > cost Of Revenue
109426000
Quarters > 0 > income Statement > gross Profit
1017535000
Quarters > 0 > income Statement > operating Expenses
776991000
Quarters > 0 > income Statement > operating Income
349970000
Quarters > 0 > income Statement > interest Expense
993000
Quarters > 0 > income Statement > pretax Income
386053000
Quarters > 0 > income Statement > net Income
344258000
Quarters > 0 > income Statement > eps
-
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
-
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
31.05431332583825
Quarters > 0 > income Statement > total Other Income Expense Net
-5624000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
-
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
-
Quarters > 0 > balance Sheet > property Plant Equipment
-
Quarters > 0 > balance Sheet > total Assets
-
Quarters > 0 > balance Sheet > payables
-
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
-
Quarters > 0 > balance Sheet > equity
-
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
344258000
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
-
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-
Quarters > 0 > ratios > PB
-
Quarters > 0 > ratios > ROE
-
Quarters > 0 > ratios > ROA
-
Quarters > 0 > ratios > FCF
-
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
46
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
947961000
Quarters > 1 > income Statement > cost Of Revenue
110747000
Quarters > 1 > income Statement > gross Profit
837214000
Quarters > 1 > income Statement > operating Expenses
744120000
Quarters > 1 > income Statement > operating Income
203841000
Quarters > 1 > income Statement > interest Expense
1126000
Quarters > 1 > income Statement > pretax Income
286899000
Quarters > 1 > income Statement > net Income
245358000
Quarters > 1 > income Statement > eps
4.011329646289264
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
61166252
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
21.50309981106818
Quarters > 1 > income Statement > total Other Income Expense Net
45785000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
2085976000
Quarters > 1 > balance Sheet > short Term Investments
1842200000
Quarters > 1 > balance Sheet > receivables
1126445000
Quarters > 1 > balance Sheet > inventories
340621000
Quarters > 1 > balance Sheet > total Current Assets
5829739000
Quarters > 1 > balance Sheet > property Plant Equipment
45795000
Quarters > 1 > balance Sheet > total Assets
7175592000
Quarters > 1 > balance Sheet > payables
852203000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
1079840000
Quarters > 1 > balance Sheet > equity
6095752000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
213682280
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-
Quarters > 1 > cash Flow > net Change In Cash
-
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
4.011329646289264
Quarters > 1 > ratios > PB
8.196972458656454
Quarters > 1 > ratios > ROE
4.025065324179855
Quarters > 1 > ratios > ROA
3.419341567915233
Quarters > 1 > ratios > FCF
-
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
56
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
790683000
Quarters > 2 > income Statement > cost Of Revenue
80805000
Quarters > 2 > income Statement > gross Profit
709878000
Quarters > 2 > income Statement > operating Expenses
649436000
Quarters > 2 > income Statement > operating Income
141247000
Quarters > 2 > income Statement > interest Expense
1135000
Quarters > 2 > income Statement > pretax Income
202361000
Quarters > 2 > income Statement > net Income
169469000
Quarters > 2 > income Statement > eps
-
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
-
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
17.863922709859704
Quarters > 2 > income Statement > total Other Income Expense Net
25131000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
-
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
-
Quarters > 2 > balance Sheet > property Plant Equipment
-
Quarters > 2 > balance Sheet > total Assets
-
Quarters > 2 > balance Sheet > payables
-
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
-
Quarters > 2 > balance Sheet > equity
-
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
149319140
Quarters > 2 > cash Flow > depreciation
-
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
-
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-
Quarters > 2 > ratios > PB
-
Quarters > 2 > ratios > ROE
-
Quarters > 2 > ratios > ROA
-
Quarters > 2 > ratios > FCF
-
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
46
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
738411000
Quarters > 3 > income Statement > cost Of Revenue
72656000
Quarters > 3 > income Statement > gross Profit
665755000
Quarters > 3 > income Statement > operating Expenses
636854000
Quarters > 3 > income Statement > operating Income
101557000
Quarters > 3 > income Statement > interest Expense
704000
Quarters > 3 > income Statement > pretax Income
86509000
Quarters > 3 > income Statement > net Income
774161000
Quarters > 3 > income Statement > eps
12.741092935715281
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
60760957
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
13.753451668515233
Quarters > 3 > income Statement > total Other Income Expense Net
-34670000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
1499936000
Quarters > 3 > balance Sheet > short Term Investments
1878890000
Quarters > 3 > balance Sheet > receivables
817707000
Quarters > 3 > balance Sheet > inventories
407233000
Quarters > 3 > balance Sheet > total Current Assets
4883103000
Quarters > 3 > balance Sheet > property Plant Equipment
43518000
Quarters > 3 > balance Sheet > total Assets
6202522000
Quarters > 3 > balance Sheet > payables
482702000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
704239000
Quarters > 3 > balance Sheet > equity
5498283000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
736691610
Quarters > 3 > cash Flow > depreciation
-
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-
Quarters > 3 > cash Flow > net Change In Cash
-
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
12.741092935715281
Quarters > 3 > ratios > PB
9.027477445831726
Quarters > 3 > ratios > ROE
14.080050081088952
Quarters > 3 > ratios > ROA
12.481390634325845
Quarters > 3 > ratios > FCF
-
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
67
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
2190231000
Annuals > 0 > income Statement > cost Of Revenue
227289000
Annuals > 0 > income Statement > gross Profit
1962942000
Annuals > 0 > income Statement > operating Expenses
2208075000
Annuals > 0 > income Statement > operating Income
-17844000
Annuals > 0 > income Statement > interest Expense
2464000
Annuals > 0 > income Statement > pretax Income
85180000
Annuals > 0 > income Statement > net Income
833040000
Annuals > 0 > income Statement > eps
13.710119806045846
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
60760957
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-0.8147085855327588
Annuals > 0 > income Statement > total Other Income Expense Net
-33252000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
1499936000
Annuals > 0 > balance Sheet > short Term Investments
1878890000
Annuals > 0 > balance Sheet > receivables
817707000
Annuals > 0 > balance Sheet > inventories
407233000
Annuals > 0 > balance Sheet > total Current Assets
4883103000
Annuals > 0 > balance Sheet > property Plant Equipment
43518000
Annuals > 0 > balance Sheet > total Assets
6202522000
Annuals > 0 > balance Sheet > payables
482702000
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
704239000
Annuals > 0 > balance Sheet > equity
5498283000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
833040000
Annuals > 0 > cash Flow > depreciation
17527000
Annuals > 0 > cash Flow > change In Working Capital
-325173000
Annuals > 0 > cash Flow > cash From Operations
-82747000
Annuals > 0 > cash Flow > capital Expenditures
68301000
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
279759000
Annuals > 0 > cash Flow > net Change In Cash
-520582000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
13.710119806045846
Annuals > 0 > ratios > PB
9.027477445831726
Annuals > 0 > ratios > ROE
15.150911657330116
Annuals > 0 > ratios > ROA
13.430665784014954
Annuals > 0 > ratios > FCF
-151048000
Annuals > 0 > ratios > Piotroski FScore
2
Annuals > 0 > ratios > fcf Percent
-0.06896441516899358
Annuals > 0 > health Score
60
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
1226316000
Annuals > 1 > income Statement > cost Of Revenue
117835000
Annuals > 1 > income Statement > gross Profit
1108481000
Annuals > 1 > income Statement > operating Expenses
1646954000
Annuals > 1 > income Statement > operating Income
-420638000
Annuals > 1 > income Statement > interest Expense
904000
Annuals > 1 > income Statement > pretax Income
-304496000
Annuals > 1 > income Statement > net Income
-295053000
Annuals > 1 > income Statement > eps
-4.984467472714689
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
59194488
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-34.300946901124995
Annuals > 1 > income Statement > total Other Income Expense Net
24084000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
2048844000
Annuals > 1 > balance Sheet > short Term Investments
1131000000
Annuals > 1 > balance Sheet > receivables
417994000
Annuals > 1 > balance Sheet > inventories
310550000
Annuals > 1 > balance Sheet > total Current Assets
4123737000
Annuals > 1 > balance Sheet > property Plant Equipment
22676000
Annuals > 1 > balance Sheet > total Assets
4542458000
Annuals > 1 > balance Sheet > payables
245557000
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
444951000
Annuals > 1 > balance Sheet > equity
4097507000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-272333920
Annuals > 1 > cash Flow > depreciation
111307000
Annuals > 1 > cash Flow > change In Working Capital
-308891000
Annuals > 1 > cash Flow > cash From Operations
-420327000
Annuals > 1 > cash Flow > capital Expenditures
43812000
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
1336727000
Annuals > 1 > cash Flow > net Change In Cash
1224610000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-4.984467472714689
Annuals > 1 > ratios > PB
11.801316568147413
Annuals > 1 > ratios > ROE
-7.200793067589635
Annuals > 1 > ratios > ROA
-6.495448059178532
Annuals > 1 > ratios > FCF
-464139000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-0.3784823813764152
Annuals > 1 > health Score
27
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
410746000
Annuals > 2 > income Statement > cost Of Revenue
29431000
Annuals > 2 > income Statement > gross Profit
381315000
Annuals > 2 > income Statement > operating Expenses
1130409000
Annuals > 2 > income Statement > operating Income
-719663000
Annuals > 2 > income Statement > interest Expense
3906000
Annuals > 2 > income Statement > pretax Income
-729314000
Annuals > 2 > income Statement > net Income
-709594000
Annuals > 2 > income Statement > eps
-12.80951412683288
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
55395856
Annuals > 2 > income Statement > income Tax Expense
-19720000
Annuals > 2 > income Statement > EBITDA
-725408000
Annuals > 2 > income Statement > operating Margin
-175.20876648829204
Annuals > 2 > income Statement > total Other Income Expense Net
-33409000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
800740000
Annuals > 2 > balance Sheet > short Term Investments
1391808000
Annuals > 2 > balance Sheet > receivables
241228000
Annuals > 2 > balance Sheet > inventories
228353000
Annuals > 2 > balance Sheet > total Current Assets
2774197000
Annuals > 2 > balance Sheet > property Plant Equipment
16235000
Annuals > 2 > balance Sheet > total Assets
3134261000
Annuals > 2 > balance Sheet > payables
188721000
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
320561000
Annuals > 2 > balance Sheet > equity
2813700000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-669147140
Annuals > 2 > cash Flow > depreciation
103631000
Annuals > 2 > cash Flow > change In Working Capital
-375722000
Annuals > 2 > cash Flow > cash From Operations
-862807000
Annuals > 2 > cash Flow > capital Expenditures
837000
Annuals > 2 > cash Flow > cash From Investing
-461184000
Annuals > 2 > cash Flow > cash From Financing
843757000
Annuals > 2 > cash Flow > net Change In Cash
-533936000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-12.80951412683288
Annuals > 2 > ratios > PB
16.08304892717774
Annuals > 2 > ratios > ROE
-25.219248676120408
Annuals > 2 > ratios > ROA
-22.639914161583864
Annuals > 2 > ratios > FCF
-863644000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-2.1026230322389017
Annuals > 2 > health Score
27
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
497277000
Annuals > 3 > income Statement > cost Of Revenue
0
Annuals > 3 > income Statement > gross Profit
497277000
Annuals > 3 > income Statement > operating Expenses
857175000
Annuals > 3 > income Statement > operating Income
-359898000
Annuals > 3 > income Statement > interest Expense
1096000
Annuals > 3 > income Statement > pretax Income
-399743000
Annuals > 3 > income Statement > net Income
-408265000
Annuals > 3 > income Statement > eps
-7.901651137645963
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
51668315
Annuals > 3 > income Statement > income Tax Expense
8522000
Annuals > 3 > income Statement > EBITDA
-354031000
Annuals > 3 > income Statement > operating Margin
-72.37374742849558
Annuals > 3 > income Statement > total Other Income Expense Net
-42239000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
1334676000
Annuals > 3 > balance Sheet > short Term Investments
1002052000
Annuals > 3 > balance Sheet > receivables
28058000
Annuals > 3 > balance Sheet > inventories
109076000
Annuals > 3 > balance Sheet > total Current Assets
2542971000
Annuals > 3 > balance Sheet > property Plant Equipment
15843000
Annuals > 3 > balance Sheet > total Assets
2850274000
Annuals > 3 > balance Sheet > payables
208850000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
316050000
Annuals > 3 > balance Sheet > equity
2534224000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-368050900
Annuals > 3 > cash Flow > depreciation
5397000
Annuals > 3 > cash Flow > change In Working Capital
-340951000
Annuals > 3 > cash Flow > cash From Operations
-606812000
Annuals > 3 > cash Flow > capital Expenditures
3623000
Annuals > 3 > cash Flow > cash From Investing
-347070000
Annuals > 3 > cash Flow > cash From Financing
1121342000
Annuals > 3 > cash Flow > net Change In Cash
117873000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-7.901651137645963
Annuals > 3 > ratios > PB
16.655136453407433
Annuals > 3 > ratios > ROE
-16.110059726369887
Annuals > 3 > ratios > ROA
-14.323710632732151
Annuals > 3 > ratios > FCF
-610435000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-1.227555265978519
Annuals > 3 > health Score
27
Valuation > metrics > PE
34.97
Valuation > final Score
38.036
Valuation > verdict
39.9% Overvalued
Profitability > metrics > Net Margin
0.3054746348808876
Profitability > final Score
65
Profitability > verdict
Adequate
Risk > metrics > Interest Coverage
352.4370594159114
Risk > final Score
70
Risk > verdict
Low
Liquidity > final Score
50
Liquidity > verdict
Weak
Prev Valuations > 0
40
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
51
Prev Profitabilities > 1
65
Prev Profitabilities > 2
88
Prev Risks > 0
100
Prev Risks > 1
70
Prev Risks > 2
100
Prev Liquidities > 0
100
Prev Liquidities > 1
50
Prev Liquidities > 2
100
Updated At
2026-01-20T21:24:34.103Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-02-26
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
AfterMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
4
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2022-12-31
Earnings History > 1 > report Date
2023-03-01
Earnings History > 1 > date
2022-12-31
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
USD
Earnings History > 1 > eps Actual
-0.7
Earnings History > 1 > eps Estimate
-3.46
Earnings History > 1 > eps Difference
2.76
Earnings History > 1 > surprise Percent
79.7688
Earnings History > 2 > period
2022-09-30
Earnings History > 2 > report Date
2022-10-26
Earnings History > 2 > date
2022-09-30
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-4.26
Earnings History > 2 > eps Estimate
-3.64
Earnings History > 2 > eps Difference
-0.62
Earnings History > 2 > surprise Percent
-17.033
Earnings History > 3 > period
2022-06-30
Earnings History > 3 > report Date
2022-07-27
Earnings History > 3 > date
2022-06-30
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-3.8
Earnings History > 3 > eps Estimate
-4.64
Earnings History > 3 > eps Difference
0.84
Earnings History > 3 > surprise Percent
18.1034
Earnings History > 4 > period
2022-03-31
Earnings History > 4 > report Date
2022-05-04
Earnings History > 4 > date
2022-03-31
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-4.36
Earnings History > 4 > eps Estimate
-5.91
Earnings History > 4 > eps Difference
1.55
Earnings History > 4 > surprise Percent
26.2267
Earnings History > 5 > period
2021-12-31
Earnings History > 5 > report Date
2022-03-02
Earnings History > 5 > date
2021-12-31
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-5.06
Earnings History > 5 > eps Estimate
-5.98
Earnings History > 5 > eps Difference
0.92
Earnings History > 5 > surprise Percent
15.3846
Earnings History > 6 > period
2021-09-30
Earnings History > 6 > report Date
2021-10-27
Earnings History > 6 > date
2021-09-30
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-4.1
Earnings History > 6 > eps Estimate
-4.77
Earnings History > 6 > eps Difference
0.67
Earnings History > 6 > surprise Percent
14.0461
Earnings History > 7 > period
2021-06-30
Earnings History > 7 > report Date
2021-07-28
Earnings History > 7 > date
2021-06-30
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
1.98
Earnings History > 7 > eps Estimate
-1.83
Earnings History > 7 > eps Difference
3.81
Earnings History > 7 > surprise Percent
208.1967
Earnings History > 8 > period
2021-03-31
Earnings History > 8 > report Date
2021-05-13
Earnings History > 8 > date
2021-03-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.81
Earnings History > 8 > eps Estimate
-2.36
Earnings History > 8 > eps Difference
1.55
Earnings History > 8 > surprise Percent
65.678
Earnings History > 9 > period
2020-12-31
Earnings History > 9 > report Date
2021-03-03
Earnings History > 9 > date
2020-12-31
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-4.31
Earnings History > 9 > eps Estimate
-3.05
Earnings History > 9 > eps Difference
-1.26
Earnings History > 9 > surprise Percent
-41.3115
Earnings History > 10 > period
2020-09-30
Earnings History > 10 > report Date
2020-10-21
Earnings History > 10 > date
2020-09-30
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-3.97
Earnings History > 10 > eps Estimate
-3.02
Earnings History > 10 > eps Difference
-0.95
Earnings History > 10 > surprise Percent
-31.457
Earnings History > 11 > period
2020-06-30
Earnings History > 11 > report Date
2020-07-29
Earnings History > 11 > date
2020-06-30
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-3.21
Earnings History > 11 > eps Estimate
-2.63
Earnings History > 11 > eps Difference
-0.58
Earnings History > 11 > surprise Percent
-22.0532
Earnings History > 12 > period
2020-03-31
Earnings History > 12 > report Date
2020-05-13
Earnings History > 12 > date
2020-03-31
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-2.06
Earnings History > 12 > eps Estimate
-1.41
Earnings History > 12 > eps Difference
-0.65
Earnings History > 12 > surprise Percent
-46.0993
Earnings History > 13 > period
2019-12-31
Earnings History > 13 > report Date
2020-02-26
Earnings History > 13 > date
2019-12-31
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-2.66
Earnings History > 13 > eps Estimate
-1.39
Earnings History > 13 > eps Difference
-1.27
Earnings History > 13 > surprise Percent
-91.3669
Earnings History > 14 > period
2019-09-30
Earnings History > 14 > report Date
2019-10-23
Earnings History > 14 > date
2019-09-30
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.72
Earnings History > 14 > eps Estimate
-1.1
Earnings History > 14 > eps Difference
0.38
Earnings History > 14 > surprise Percent
34.5455
Earnings History > 15 > period
2019-06-30
Earnings History > 15 > report Date
2019-08-01
Earnings History > 15 > date
2019-06-30
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-1.55
Earnings History > 15 > eps Estimate
-0.96
Earnings History > 15 > eps Difference
-0.59
Earnings History > 15 > surprise Percent
-61.4583
Earnings History > 16 > period
2019-03-31
Earnings History > 16 > report Date
2019-05-09
Earnings History > 16 > date
2019-03-31
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
0.17
Earnings History > 16 > eps Estimate
0.18
Earnings History > 16 > eps Difference
-0.01
Earnings History > 16 > surprise Percent
-5.5556
Earnings History > 17 > period
2018-12-31
Earnings History > 17 > report Date
2019-02-28
Earnings History > 17 > date
2018-12-31
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.9
Earnings History > 17 > eps Estimate
-0.84
Earnings History > 17 > eps Difference
-0.06
Earnings History > 17 > surprise Percent
-7.1429
Earnings History > 18 > period
2018-09-30
Earnings History > 18 > report Date
2018-10-24
Earnings History > 18 > date
2018-09-30
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.51
Earnings History > 18 > eps Estimate
-0.59
Earnings History > 18 > eps Difference
0.08
Earnings History > 18 > surprise Percent
13.5593
Earnings History > 19 > period
2018-06-30
Earnings History > 19 > report Date
2018-08-01
Earnings History > 19 > date
2018-06-30
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.07
Earnings History > 19 > eps Estimate
-0.45
Earnings History > 19 > eps Difference
0.38
Earnings History > 19 > surprise Percent
84.4444
Earnings History > 20 > period
2018-03-31
Earnings History > 20 > report Date
2018-05-08
Earnings History > 20 > date
2018-03-31
Earnings History > 20 > before After Market
AfterMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.55
Earnings History > 20 > eps Estimate
-0.18
Earnings History > 20 > eps Difference
-0.37
Earnings History > 20 > surprise Percent
-205.5556
Earnings History > 21 > period
2017-09-30
Earnings History > 21 > report Date
2017-10-25
Earnings History > 21 > date
2017-09-30
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.41
Earnings History > 21 > eps Estimate
-0.39
Earnings History > 21 > eps Difference
-0.02
Earnings History > 21 > surprise Percent
-5.1282
Earnings History > 22 > period
2017-06-30
Earnings History > 22 > report Date
2017-08-23
Earnings History > 22 > date
2017-06-30
Earnings History > 22 > before After Market
AfterMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
0.01
Earnings History > 22 > eps Estimate
-0.24
Earnings History > 22 > eps Difference
0.25
Earnings History > 22 > surprise Percent
104.1667
Earnings History > 23 > period
2017-03-31
Earnings History > 23 > report Date
2017-05-02
Earnings History > 23 > date
2017-03-31
Earnings History > 23 > before After Market
BeforeMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
0.0091
Earnings History > 23 > eps Estimate
0
Earnings History > 23 > eps Difference
0.0091
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2016-12-31
Earnings History > 24 > report Date
2017-03-14
Earnings History > 24 > date
2016-12-31
Earnings History > 24 > before After Market
AfterMarket
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-0.44
Earnings History > 24 > eps Estimate
-0.23
Earnings History > 24 > eps Difference
-0.21
Earnings History > 24 > surprise Percent
-91.3043
Earnings History > 25 > period
2016-09-30
Earnings History > 25 > report Date
2016-10-26
Earnings History > 25 > date
2016-09-30
Earnings History > 25 > before After Market
AfterMarket
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-0.26
Earnings History > 25 > eps Estimate
-0.14
Earnings History > 25 > eps Difference
-0.12
Earnings History > 25 > surprise Percent
-85.7143
Earnings History > 26 > period
2016-06-30
Earnings History > 26 > report Date
2016-08-25
Earnings History > 26 > date
2016-06-30
Earnings History > 26 > before After Market
AfterMarket
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-0.23
Earnings History > 26 > eps Estimate
-0.34
Earnings History > 26 > eps Difference
0.11
Earnings History > 26 > surprise Percent
32.3529
Earnings History > 27 > period
2016-03-31
Earnings History > 27 > report Date
2016-05-10
Earnings History > 27 > date
2016-03-31
Earnings History > 27 > before After Market
AfterMarket
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-0.19
Earnings History > 27 > eps Estimate
-0.41
Earnings History > 27 > eps Difference
0.22
Earnings History > 27 > surprise Percent
53.6585
Earnings History > 28 > period
2015-12-31
Earnings History > 28 > report Date
2016-03-10
Earnings History > 28 > date
2015-12-31
Earnings History > 28 > before After Market
AfterMarket
Earnings History > 28 > currency
USD
Earnings History > 28 > eps Actual
-0.33
Earnings History > 28 > eps Estimate
-0.27
Earnings History > 28 > eps Difference
-0.06
Earnings History > 28 > surprise Percent
-22.2222
Earnings History > 29 > period
2015-09-30
Earnings History > 29 > report Date
2015-11-16
Earnings History > 29 > date
2015-09-30
Earnings History > 29 > before After Market
AfterMarket
Earnings History > 29 > currency
USD
Earnings History > 29 > eps Actual
-0.19
Earnings History > 29 > eps Estimate
-0.31
Earnings History > 29 > eps Difference
0.12
Earnings History > 29 > surprise Percent
38.7097
Earnings History > 30 > period
2015-03-31
Earnings History > 30 > report Date
2015-05-14
Earnings History > 30 > date
2015-03-31
Earnings History > 30 > before After Market
AfterMarket
Earnings History > 30 > currency
USD
Earnings History > 30 > eps Actual
-0.2866
Earnings History > 30 > eps Estimate
-0.1
Earnings History > 30 > eps Difference
-0.1866
Earnings History > 30 > surprise Percent
-186.6
Earnings History > 31 > period
2014-12-31
Earnings History > 31 > report Date
2015-03-19
Earnings History > 31 > date
2014-12-31
Earnings History > 31 > before After Market
AfterMarket
Earnings History > 31 > currency
USD
Earnings History > 31 > eps Actual
-0.53
Earnings History > 31 > eps Estimate
-0.09
Earnings History > 31 > eps Difference
-0.44
Earnings History > 31 > surprise Percent
-488.8889
Earnings History > 32 > period
2014-09-30
Earnings History > 32 > report Date
2014-11-14
Earnings History > 32 > date
2014-09-30
Earnings History > 32 > before After Market
BeforeMarket
Earnings History > 32 > currency
USD
Earnings History > 32 > eps Actual
-0.3102
Earnings History > 32 > eps Estimate
-0.17
Earnings History > 32 > eps Difference
-0.1402
Earnings History > 32 > surprise Percent
-82.4706
Earnings History > 33 > period
2014-03-31
Earnings History > 33 > report Date
2014-06-30
Earnings History > 33 > date
2014-03-31
Earnings History > 33 > before After Market
-
Earnings History > 33 > currency
USD
Earnings History > 33 > eps Actual
-0.1732
Earnings History > 33 > eps Estimate
0
Earnings History > 33 > eps Difference
-0.1732
Earnings History > 33 > surprise Percent
-
Earnings History > 34 > period
2013-12-31
Earnings History > 34 > report Date
2014-03-31
Earnings History > 34 > date
2013-12-31
Earnings History > 34 > before After Market
-
Earnings History > 34 > currency
USD
Earnings History > 34 > eps Actual
-14.2535
Earnings History > 34 > eps Estimate
0
Earnings History > 34 > eps Difference
-14.2535
Earnings History > 34 > surprise Percent
-
Earnings History > 35 > period
2013-09-30
Earnings History > 35 > report Date
2013-12-31
Earnings History > 35 > date
2013-09-30
Earnings History > 35 > before After Market
-
Earnings History > 35 > currency
USD
Earnings History > 35 > eps Actual
-10.7263
Earnings History > 35 > eps Estimate
0
Earnings History > 35 > eps Difference
-10.7263
Earnings History > 35 > surprise Percent
-
Earnings History > 36 > period
2013-03-31
Earnings History > 36 > report Date
2013-06-30
Earnings History > 36 > date
2013-03-31
Earnings History > 36 > before After Market
-
Earnings History > 36 > currency
USD
Earnings History > 36 > eps Actual
-21.7745
Earnings History > 36 > eps Estimate
0
Earnings History > 36 > eps Difference
-21.7745
Earnings History > 36 > surprise Percent
-
Earnings History > 37 > period
2012-12-31
Earnings History > 37 > report Date
2013-03-31
Earnings History > 37 > date
2012-12-31
Earnings History > 37 > before After Market
-
Earnings History > 37 > currency
USD
Earnings History > 37 > eps Actual
-12.8914
Earnings History > 37 > eps Estimate
0
Earnings History > 37 > eps Difference
-12.8914
Earnings History > 37 > surprise Percent
-
argenx SE, a commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally. The company offers VYGART and VYGART HYTRULO to treat generalized myasthenia gravis (gMG), immune thrombocytopenia (ITP), and chronic inflammatory demyelinating polyneuropathy (CIDP). It also develops efgartigimod for the treatment of seronegative and ocular gMG, thyroid eye diseases, ITP, myositis, Sjögren's disease, lupus nephropathy, systemic sclerosis, antibody-mediated rejection, and autoimmune encephalitis; empasiprubart for multifocal motor neuropath, CIDP, delayed graft function, and dermatomyositis; and ARGX-119 for congenital myasthenic syndrome, amyotrophic lateral sclerosis, and spinal muscular atrophy. In addition, the company is also developing ARGX-119, a MuSK agonist to treat congenital myasthenic syndromes and amyotrophic lateral sclerosis; ARGX-109, which targets IL-6 to treat inflammation; ARGX-121 and ARGX 220 that targets the immune system; ARGX-213, which targets FcRn; and ARGX-118, which develops antibodies against Galectin-10, as well as cusatuzumab, ARGX-112, ARGX-114, and ARGX-115. It has strategic collaborations with OncoVerity, Inc, LEO Pharma A/S, Zai Lab Limited, AbbVie, Inc., Elektrofi, Genmab SE, Chugai Pharmaceutical Co., Ltd., Clayton Foundation, Halozyme Therapeutics, Inc., AgomAb Therapeutics NV, Broteio Pharma B.V., VIB vzw, University of Texas, BioWa, Inc., Lonza Sales AG, Université Catholique de Louvain, Sopartec S.A., NYU Langone Health, Leiden University Medical Center, and IQVIA Ltd. argenx SE was incorporated in 2008 and is based in Amsterdam, the Netherlands.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/Aargenx: TED Phase 3 Failure, Vyvgart Growth, And Why I'm Still A Hold (NASDAQ:ARGX) - Seeking Alpha
12/17/2025
argenx: TED Phase 3 Failure, Vyvgart Growth, And Why I'm Still A Hold (NASDAQ:ARGX) Seeking Alpha
Read more →argenx SE (ARGNF) Q3 2025 Earnings Call Highlights: Record Sales and Strategic Pipeline Advancements Yahoo Finance
Read more →Showing 2 of 9
(Last Updated 2025-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
Low
Low ≥ 50
High ≤ 10
* Institutions hold a combined 0.00% of the total shares of argenx SE
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
4
Date
2022-12-31
EPS Actual
-0.7
EPS Estimate
-3.46
EPS Difference
2.76
Surprise Percent
79.7688%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.